Intraluminal instillation of urokinase and autologous plasma: a method to unblock occluded central venous ports
- PMID: 16635269
- PMCID: PMC1501039
- DOI: 10.1186/1471-2407-6-103
Intraluminal instillation of urokinase and autologous plasma: a method to unblock occluded central venous ports
Abstract
Background: Therapeutic use and effective function of recombinant urokinase (r-UK) for occluded ports need the presence of plasminogen.
Methods: As a therapeutic proof of principle, we demonstrate that the use of r-UK and autologous plasma effectively reestablishes the function of occluded central venous ports (CVP) resistant to routine management of catheter occlusion. Five patients with occluded ports resistant to the routine management were treated.
Results: All patients were successfully treated with thrombolytic therapy using intraluminal instillation of r-UK and autologous plasma.
Conclusion: Instillation of r-UK and autologous plasma is a safe and effective method for management of CVP occlusion.
Similar articles
-
Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.Thromb Haemost. 2004 Sep;92(3):575-82. doi: 10.1160/TH03-11-0686. Thromb Haemost. 2004. PMID: 15351854 Clinical Trial.
-
Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.Crit Care Med. 2004 Oct;32(10):1990-6. doi: 10.1097/01.ccm.0000142706.01717.eb. Crit Care Med. 2004. PMID: 15483405 Clinical Trial.
-
Dose-ranging trial with a recombinant urokinase (urokinase alfa) for occluded central venous catheters in oncology patients.J Vasc Interv Radiol. 2004 Jun;15(6):575-80. doi: 10.1097/01.rvi.0000124950.24134.19. J Vasc Interv Radiol. 2004. PMID: 15178717 Clinical Trial.
-
Interventions for restoring patency of occluded central venous catheter lumens (Review).Evid Based Child Health. 2013 Mar 7;8(2):695–749. doi: 10.1002/ebch.1907. Evid Based Child Health. 2013. PMID: 24482900 Review. No abstract available.
-
Venous access in pediatric oncology patients.Semin Surg Oncol. 1993 Nov-Dec;9(6):467-77. doi: 10.1002/ssu.2980090604. Semin Surg Oncol. 1993. PMID: 8284565 Review.
Cited by
-
Clearing obstructed totally implantable central venous access ports: an efficient protocol using a second needle.Support Care Cancer. 2012 Nov;20(11):2859-64. doi: 10.1007/s00520-012-1412-0. Epub 2012 Mar 2. Support Care Cancer. 2012. PMID: 22382590
References
-
- Glynn MF, Langer B, Jeejeebhoy KN. Therapy for thrombotic occlusion of long-term intravenous alimentation catheters. JPEN J Parenter Enteral Nutr. 1980;4:387–390. - PubMed
-
- Hurtubise MR, Bottino JC, Lawson M, McCredie KB. Restoring patency of occluded central venous catheters. Arch Surg. 1980;115:212–213. - PubMed
-
- Collen D, Lijnen HR. Thrombolytic agents. Thromb Haemost. 2005;93:627–630. - PubMed
-
- Wachs T. Urokinase administration in pediatric patients with occluded central venous catheters. J Intraven Nurs. 1990;13:100–102. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials